PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
1996 | 43 | 1 |

Tytuł artykułu

Stucture-activity relationships for phosphorylation of nucleoside analogs to monophosphates by nucleoside kinases

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
The mammalian deoxyribonucleoside kinases thymidine kinase 1 and 2, deoxy- cytidine kinase and deoxyguanosine kinase phosphorylate deoxyribonucleosides and provide an alternative to de novo synthesis of DNA precursors. Their activities are essential for activation of several chemotherapeutically important nucleoside analogs. These four salvage kinase enzymes exhibit distinct substrate specificities for nucleoside analogs modified in the base and glycon moieties. In this review their, structure-activity relationships are discussed. Alternative routes for phosphorylation of nucleoside analogs are also reviewed, such as the phosphotransfer capacity of 5'-nucleotidase and protein kinases.

Wydawca

-

Rocznik

Tom

43

Numer

1

Opis fizyczny

p.143-160

Twórcy

  • Medivir AB, Lunastigen 7, S-141 44 Huddinge, Sweden
autor

Bibliografia

  • 1. Plagemann, P.G., Wohlhueter, R.M. & Woffendin, C. (1988) Nucleoside and nucleo- base transport in animal cells. Biochim. Biophys. Acta 947,405-443.
  • 2. Plagemann, P.G. & Woffendin, C. (1989) Permeation and salvage of dideoxyadenosine in mammalian cells. Mol. Pharmacol. 36,185-192.
  • 3. Hurley, M.C., Lin, B.B. & Fox, i.H. (1985) Regulation of deoxyadenosine and nucleoside analog phosphorylation by human placental adenosine kinase. J. Biol. Chan. 260, 15675- 15681.
  • 4. Yamada. V., Goto, II. & Ogasawara. N. (1981) Adenosine kinase from human liver. Biochim. Biophys. Acta 660,36-43.
  • 5. Arner, E.S.J. & Friksson, S. (1995) Mammalian deoxyribonucleoside kinases. Pharmacol. Thcr. 67,155-186.
  • 6. Cohen, A., Barankiewicz, J., Lederman, I I.M. & Gelfand, E.VV. (1983) Purine and pyrimidine metabolism in human T lymphocytes. Regu­lation of deoxyribonucleotide metabolism. /. Biol. Chcm. 258," 12334-11340.
  • 7. Spyrou, G. & Reichard, R. (1989) Intracellular compartmentation of deoxyevtidine nucleotide pools in S phase mouse 3T3 fibroblasts. /. Biol. Chcm. 264,960-964.
  • 8. Spasokoukotskaja, T., Taljanidisz. M., Sasvari- Sz«?kely, M. & Staub, M. (1991) Deoxycytidine is salvaged not only into DNA but also into phospholipid precursors. III. dCDP-diacvl- glyccrol formation in tonsillar lymphocytes. Biochem. Biophys. Res. Commun. 174,680-687.
  • 9. Hrabak, A., Spasokukotskaja, T., Temesi, A. & Staub, M. (1993) The salvage of deoxycytidine into dCDP-diacvlglycerol by macrophages and Ivmphocytes. Biochem. Biophys. Res. Commun. 193,212-219.
  • 10. Kunz, B.A. (1988) Mutagenesis and deoxyribo­nucleotide pool imbalance. Mutation Res. 200, 133-147.
  • 11. Meuth, M. (1989) The molecular basis of mutations induced by deoxyribonucleoside tri­phosphate pool imbalances in mammalian cells. Exp. Cell. Res. 181, 305-316.
  • 12. Shugar, D. (1992) Phosphorylating enzymes involved in activation of chemotherapeutic nucleosides and nucleotides; in Proceedings of the Third International Symposium on Molecular Aspects of Chemotherapy, Gdansk, Poland, June 19-21, 1991 (Shugar. I)., Rode, W. & Borowski, E., eds.) pp. 239-270, Springer Verlag, Berlin, I leidelberg, New York.
  • 13. Plunkett, W. & Saunders, P.P. (1991) Metabolism and action of purine nucleoside analogs. Pharmacol. Ther. 49,239-268.
  • 14. Ruiz van Haperen. V.W.T. & Peters, G.J. (1994) New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxy­cytidine kinase. Pharm. World Sci. 16, 104-112.
  • 15. Shugar, D. (1974) Progress with antiviral agents. FEBS Lett. 40 (Suppl.), S48-S62.
  • 16. Munch-Petersen, A. (ed.) (1983) Metabolism of Nucleotides, Nucleosides and Nucleobases in Microorganisms. Academic Press, Iondon.
  • 17. Kit, S. (1985) ITivmidine kinase. Microbiol. Sci. 2, 369 375.
  • 18. Gentry, G.A. (1992) Viral thymidine kinases and their relatives. Pharmacol. Ther. 54,319-355.
  • 19. Bohman, C. & Eriksson, S. (1990) Mammalian deoxynucleoside kinases. Biochem (I.ife Sci. Adv.) 9,11-35.
  • 20. Weber, G.,Singhal, R.L., Abonvi, M., Prajda, N., Hata, Y.,Szckeres, T., Yeh, A. & Look, K.Y. (1993) Regulation of deoxycytidine kinase activity and inhibition bv DFDC. Adv. Enzyme Regul. 33, 39-59.
  • 21. Ruiz van Haperen, V.W.T., Veerman, G., Braakhuis, B.J.M., Vermoken, J.B., Boven, F.., I.eyva, A. & Peters, G.J. (1993) Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts. Eur. J. Cancer 29 A, 2132-2137.
  • 22. De Clercq, E. (1992) HIV inhibitors targeted at the reverse transcriptase. AIDS Res. Human Retrovir. 8,119-134.
  • 23. Schinazi, R.F. (1993) Competitive inhibitors of human immunodeficiency virus reverse trans­criptase. Perspecl. Drug Discovery & Design 1, 151-180.
  • 24. Johansson, N.G. (1993) Structure, antiviral activity, and chemistry of acyclic nucleoside analogues; in Advances in Antiviral Drug Design (De Clercq, E., ed.) vol. 1, pp. 87-177, JA1 Press Inc., London.
  • 25. De Clercq, E. (1984) Pyrimidine nucleoside analogues as antiviral agents; in Targets for the Design of Antiviral Agents. Proc. NATO Advanced Study Institute, Les Arcs, France, June 19-28, 1983 (De Clercq, E. & Walker, R.T., eds.) pp. 203-230, Plenum Press, New York, London.
  • 26. Heinemann, V., Xu, Y.-Z., Chubb, S., Sen, A., Hertel, L.W.,Grindey,G.B.e/a/. (1990) Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine. Mol. Pharmacol. 38,567-572.
  • 27. Plunkett, W. (1992) Modulation of deoxvcyti- dvlate deaminase in intact human leukaemia cells. Biochem. Pharmacol. 44,1819-1827.
  • 28. 1 leinemann, V., 1 lertel, LAV.. Grindey, G.B. & Plunkett, IV. (1988) Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluoro- deoxveytidine and 1 -|*-D-arabinofuranosyl- cytosine. Cancer Res. 48,4024-4031.
  • 29. Ruiz van Haperen, V.W.T., Veerman, G., Ver- inorken, J.B. & Peters, G.J. (1993) 2',2'-Difluoro- deoxycytidine (gemcitabine) incorporation into DNA and RNA of tumour cell lines. Biochem. Pharmacol. 46, 762-766.
  • 30. Bhalla, K., Holladay, C., Lutzkv, J., Ibrado. A.M., Bullock, G., Jasiok, M. et ai. (1992) Deoxv­eytidine protects normal bone marrow progenitors against ara-C and gemcitabine cytotoxicity without compromising their activity against cisplatin-resistant human ovarian cancer cells. Gynaecol. Oncol. 45,32-39.
  • 31. Tolman, R.L. (1989) Structural requirements tor enzymatic activation of acvclonucleotide analogs and the relationship to their mode of antiherpetic action; in Nucleotide Analogues as Antiviral Agents (Martin, J.C., ed.) chapter 3, pp. 35-50. ACS Symposium Series.
  • 32. Eriksson, S.. Wang, J., Gronowitz. S. & Johansson. N.G. (1995) Substrate specificities of mitochondrial thvmidine kinase and cvtosolic deoxyevtidine kinase against 5-aryl substituted pvrimidine-2'-deoxyribose analogues. Nucleosi­des & Nucleotides 14,507-510.
  • 33. Munch-Petersen, B., Cloos. L., Tyrsted, G. & Eriksson, S. (1991) Diverging substrate specifi- cilies of human thymidine kinase 1 and 2 against antiviral dideoxvnucleosides. / Biol Chem. 266,9032 9038.
  • 34. Bohman. C. & Eriksson, S. (1988) Deoxvcvtidine kinase from human leukemic spleen: prepara­tion and characteristics of homogenous enzyme. Biochemistry 27,4258-4265.
  • 35. Wang, L., Karlsson, A., Arner, F.S.J. & Eriksson, S. (1993) Substrate specificity of mitochondrial 2'-deoxyguanosine kinase. Efficient phospho­rylation of 2-chlorodeoxvadenosine. ]. Biol. Chem. 268,22847-22852.
  • 36. Eriksson, S., Kierdaszuk, B., Munch-Petersen, B., Oberg, B. & Johansson, N.G. (1991) Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxy- cytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem. Biophys. Re>. Commun. 176,586-592.
  • 37. White, J.C. & Hines. C.H. (1987) Role of uridine triphosphate in the phosphorylation of 1-ß-D-arabinofuranosvlcytosine by Ehrlich ascites tumour cells. Cancer Res. 47, 1820-1824.
  • 38. White, J.C. & Capizzi, R.L. (1991) A critical role for uridine nucleotides in the regulation of deoxveytidine kinase and the concentration dependence of 1-ß-D-arabinofuranosylcytosine phosphorylation in human leukaemia cells. Cancer Res. 51,2559-2565.
  • 39. Shewach, D.C., Reynolds, K.K. & Hertel, L.W. (1992) Nucleotide specificity of human deoxv­eytidine kinase. Mol. Pharmacol. 42,518-524.
  • 40. Coleman. C.N., Stoller, R.G., Drake, J.C. & Chabner, B.A. (1975) Deoxyevtidine kinase: properties of the enzyme from human leukemic granulocytes. Blood 46,791-803.
  • 41. Datta, N.S., Shewach. D.S., Hurlev, M.C., Mitchell, B.S. & Fox, I.H. (1989) T-lymphoblast deoxveytidine kinase: purification and properties. Biochemistry 28, 114-123.
  • 42. Datta, N.S., Shewach, D.S., Mitchell, B.S. & Fox. I.H. (1989) Kinetic proper ties and inhibition ot human l-lymphobiast deoxveytidine kinase. /. Biol. Chem.'264,9359-9364.
  • 43. Ruiz van Haperen, V.W.T., Veerman, G., Vermorken, J.B. & Peters, G.J. (1992) Interaction of metabolism of 2',2'-difluorodeoxycytidine (gemcitabine. dFdC) with normal pyrimidine metabolism. Proc. Am. /\s>
  • 44. Johnson, M.A., Johns, D.G. & Fridland, A. (1987) 2',3'-Dideoxynucleoside phosphorylation by deoxveytidine kinase from normal human thymus extracts: activation of potential drugs for AIDS therapy. Biochem. Biophys. Res. Commun. 148,1252-1258.
  • 45. Stames, M.C. & Cheng, Y.-C. (1987) Cellular metabolism of 2',3'-dideoxycytidine, a com­pound active against human immunodefi­ciency virus in vitro. J. Biol. Chem. 262,98S-991.
  • 46. Sarup, J.C., Johnson, M.A., Verhoef, V. & Fridland, A. (1989) Regulation of purine deoxy- nucleoside phosphorvlation by deoxveytidine kinase from human leukemic blast cells. Biochem. Pharmacol. 38,2601-2607.
  • 47. Kierdaszuk, B., Bohman. C., Ullman, B. & Eriksson, S. (1992) Substrate specificity of human deoxveytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs. Biochem. Pharmacol. 43,197-206.
  • 48. Ho, H.-T. & Hitchcock, M.J.M. (1989) Cellular pharmacology of 2'-3'-dideoxy-2'-3'-didehv- drothvmidine, a nucleoside analog active against human immunodeficiency virus. Antimicrob. Agents Chemother. 33,844-^19.
  • 49. Shewach, D.S., Liotta, D.C. & Schinazi, R.F. (1993) Affinity ol the antiviral enantiomers of oxathiolane cvtosine nucleosides for human 2'-deoxycvtidine kinase. Biochem. Pharmacol. 45, 1540 1343.
  • 50. Van Draanen, N.A., Tisdale, M., Parry, N.G., Jansen, R., Dornisfe. R.E., Tuttle, J.V., Averett, D.R. & Koszalka, G. (1994) Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycvtidine nucleotides. Antimicrob. Agents Chemother. 38, 868-871.
  • 51. Bennett, L.L.. Jr.. Parker, W.B., Allan. P.W.. Rose, L.M., Shealy, Y.F., Secrist, J.A., III, Montgomery, J.A., Arnett.G.. Kirkman, R.I.Shannon. VV.M. (1993) Phosphorylation of the enantiomers of the carbocvclic analog of 2'-deoxyguanosine in cells infected with herpes simplex virus type 1 and in uninfected cells. Lack of enantiomeric selectivity with the viral thymidine kinase. Mol. Pharmacol. 44, 1258-1266.
  • 52. Bohinan. C., Baizarini. J., Wigerinck, P., Van Aerschot. A., Herdewijn, P. & De Clercq, H. (1994) Mechanism of cytostatic action of novel 5-(thien-2-vl)- and 5-(furan-2-yl)-substituted pvrimidine nucleoside analogues against tumor cells transfected by the thymidine kinase gene of herpes simplex virus. /. Biol. Client. 269, 8036-8043.
  • 53. Persson, T., Hornreldt, A.-B., Gronowitz, S. & Johansson, N.G. (1994) Thienvl-substituted nucleosides and their triphosphates. Antiviral Chem. & Chemother. 5, 395-402.
  • 54. Herdewijn. P.A.M.M. (1994) 5-Substituted-2'- deoxvuridines as anti-HSV-1 agents: synthesis and structure activity relationship. Antiviral Chem. & Chemother. 5, i 31 -146.
  • 55a. Wang, J. & Eriksson. S. (1995) Phosphorylation of the antihepatitis B nucleoside analog FIAL (l-[2'-deoxy-2'-fluoro-l-($-D-arabinofuranosyl| -5-iodo-uracil) by human cvtosolic and mitochondrial thymidine kinase; implication for cytotoxicity. Submitted to Antimicrob. Agents Chemother.
  • 55b. Cheng, Y.-C, Dutchman, G., Fox, J.J., Watanabe, K.A. & Machida,). (1981) Differential activity' of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases. Antimicrob. Agents Chemother. 20,420423.
  • 56. Aswell, J.F.. Allen, G.P., Jamieson. A.T., Campbell, D.E. & Gentry, G.A. (1977) Antiviral activity of arabinosy 1 thymine in herpesviral replication: mechanism of action in vivo and in vitro. Antimicrob. Agents Chemother. 12,243-254.
  • 57. Drew, W.L., Miner, R. & King, D. (1991) Antiviral activity of FIAU (1-[2'-deoxv-2'-fluoro l-[i-D- arabinofuranosvll-5-iodo-uracil) on strains of cytomegalovirus sensitive and resistant to ganciclovir. /. Infect. Dis. 163,138S-1389.
  • 58. Fourel, I., Li, J., Hantz O., Jacquet, C., Fox, J.J. & Trepo, C. (1992) Effects of 2'-fluorinated ara- binosyl-pvrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks. /. Med. Virol. 37, 122-126.
  • 59. Dusheiko, G.M. (1994) Fialuridine toxicity: new hopes and false dawns. Int. Antiviral News 2, 22-23.
  • 60. Colacino, J.M., Malcolm, S.K. & Jaskunas, S.R. (1994) Effect of fialuridine on replication of mitochondrial DNA in CEM cells and in human hepatoblastoma cells in culture. Antimicrob. Agents Chemother. 38, 1997-2002.
  • 61. Hóglund, L. (1990) Participation of nucleo­tidases and substrate cycles in the regulation of pvrimidine deoxvnucleotide synthesis. Ph.D. Thesis, Karolińska Institute!.
  • 62. I loglund, L. & Reichard, P. (1990) Cytoplasmic 5'(3')-nucleotidase from human placenta. J. Biol. Chem. 265,6589-6595.
  • 63. Hoglund, I.. & Reichard. P. (1990) Nucleotidase activities in soluble and membrane fractions of three different mammalian cell lines. Ex}h Cell Res. 190,204-20S.
  • 64. Spychała. J., Madrid-Marina. V. & Fox. I.H. (1988) High Km soluble ^-nucleotidase from human placenta. J. Biol. Chem. 263,18759-18765.
  • 65. Itoh, R. (1993) 1MP-GMP .^-nucleotidase from rat liver. Com p. Biochem. Physiol. 105B, 13-19.
  • 66. Pesi, R., Turriani, M., Allegrini, 5., Scolozzi, C., Camici, M., Ipata, PL. & Iozzi, M.G. (1994) The Afunctional cvtosolic 5'-nucleotidase: regula­tion of the phosphotransferase and nucleotidase activities. Arch. Biochem. Biophys. 312,75-80.
  • 67. Keller, P.M., McKee, S.A. & Fyfe, J.A. (1985) Cytoplasmic 5'-nucleotidase catalyzes acyclovir phosphorylation. J. Biol. Chem. 260,8664-3667.
  • 68. Johnson, M.A. & Fridtand, A. (1989) Phospho­rylation of 2',3'-dideoxyinosine by cvtosolic 5'-nucleotidase of human lymphoid cells. Mol. Pharmacol. 36,291-295.
  • 69. Miller, W.H., Daluge, S.M., Garvev, E.P., Hopkins, S., Reardon, J.E., Boyd, F.L. & Miller, R.I . (1992) Phosphorylation of carbovir enan­tiomers by cellular enzymes determines the stereoselectivity of antiviral activity. /. Biol. Chem. 267,21220-21224.70. Saunders, P.P., Spindler, C.D., Tan, M.-T., Alvarez, F.. & Robins, R.K. (1990) Tiazofurin is phosphor via ted by threeenzymes fromChinese hamster ovary cells. Cancer Res. 50,5269-5274.
  • 71. Fr id land, A., Connelly, M.C. & Robbins, T.J. (1986) Tiazofurin metabolism in human Ivm- phoblastoid cells: evidence for phosphorylation by adenosine kinase and 5'-nucleotidase. Cancer Res. 46,532-537.
  • 72. Littler, E., Stuart. A.D. & Chee, M.S. (1992) Human cytomegalovirus UL97 open reading frameencodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature (lx>ndon) 358, 160-162.
  • 73. Sullivan. V., Talarico, C.L, Stanat, S.C., Davis, M., Coen, D.M. & Biron, K.K. (1992) A pmtein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature (London) 358,162-164.
  • 74. Lurain, N.S., Spafford, I.E. & Thompson, K.D. (1994) Mutation in theUL97open reading frame of human cytomegalovirus strains resistant to ganciclovir./. Virol. 68,4427-4431.
  • 75. Leader, D.P. (1993) Viral protein kinases and protein phosphatases. Pharmacol. Ther. 59, 343-389.
  • 76. Shugar, D. (1995) Protein kinases — enticing targets for antiviral agents. Int. Antiviral News 3, 4-6.
  • 77. Saunders, P.P., Tan, M.-T., Spindler, C.D. & Robins, R.K. (1989) Phosphorylation of 3'-deazaguanosine by nicotinamide riboside kinase in Chinese hamster ovary cells. Cancer Res. 49,6593-6599.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-article-08584f1d-cc28-41f5-a400-1bada9170d98
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.